Radiogenomics in renal cancer management—current evidence and future prospects

M Ferro, G Musi, M Marchioni, M Maggi… - International journal of …, 2023 - mdpi.com
Renal cancer management is challenging from diagnosis to treatment and follow-up. In
cases of small renal masses and cystic lesions the differential diagnosis of benign or …

Novel imaging methods for renal mass characterization: a collaborative review

E Roussel, U Capitanio, A Kutikov, E Oosterwijk… - European urology, 2022 - Elsevier
Context The incidental detection of localized renal masses has been rising steadily, but a
significant proportion of these tumors are benign or indolent and, in most cases, do not …

Role of positron emission tomography/computed tomography in the evaluation of renal cell carcinoma

R Jena, TA Narain, UP Singh… - Indian Journal of …, 2021 - journals.lww.com
Results: Several studies have shown similar sensitivity and specificity of fluoro-2-deoxy-2-d-
glucose-PET (FDG-PET) scan as compared to conventional CT scan for the initial diagnosis …

ACR Appropriateness Criteria® staging of renal cell carcinoma: 2022 update

D Ganeshan, G Khatri, N Ali, R Avery… - Journal of the American …, 2023 - Elsevier
Renal cell carcinoma is a complex group of highly heterogenous renal tumors
demonstrating variable biological behavior. Pretreatment imaging of renal cell carcinoma …

Comprehensive literature review of oral and intravenous contrast-enhanced PET/CT: a step forward?

G Metrard, C Cohen, M Bailly - Frontiers in Medicine, 2024 - frontiersin.org
The integration of diagnostic CT scans into PET/CT facilitates a comprehensive single
examination, presenting potential advantages for patients seeking a thorough one-shot …

Semi-quantitative F-18-FDG PET/computed tomography parameters for prediction of grade in patients with renal cell carcinoma and the incremental value of diuretics

H Singh, G Arora, B Nayak, A Sharma… - Nuclear Medicine …, 2020 - journals.lww.com
Objective The primary objective of the study was to evaluate the correlation between semi-
quantitative F-18 FDG PET parameters and renal cell carcinoma (RCC) grade and its role in …

Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or …

G Tatar, G Alçin, NŞ Samanci… - Nuclear Medicine …, 2022 - journals.lww.com
Role of 18F-FDG PET/CT in the assessment of therapy response... : Nuclear Medicine
Communications Role of 18F-FDG PET/CT in the assessment of therapy response and clinical …

Can 18F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell …

Y Jain, A Agrawal, A Joshi, S Menon… - Nuclear Medicine …, 2024 - journals.lww.com
Can 18F FDG PET/CT metabolic parameters be used to noninvasi... : Nuclear Medicine
Communications Can 18F FDG PET/CT metabolic parameters be used to noninvasively …

The current role of PET/CT in urological malignancies

M Lima, M Camacho, JBC Carvalheira, A Biggi… - Clinical and …, 2020 - Springer
Introduction In the past decade, there has been significant progress in the field of Nuclear
Medicine in the diagnostic evaluation of urological malignancies, mainly because of the …

Texture analysis of 3D models for the prediction of the grade of clear cell renal cell carcinoma of the kidney (pilot study)

AV Konyshev, PV Glybochko, DV Butnaru… - …, 2023 - journals.eco-vector.com
Aim. To evaluate the possibilities of textural analysis of 3D models in differentiating the
degree of nuclear dysplasia of the clear cell renal cell carcinoma (ccRCC). Materials and …